The Role of Factor XI in Coagulation: A Matter of Revision

Keywords

Computer science

References

• Inheritance and bleeding in factor XI deficiencyM. Leumann, P. Amsler, Esther Bravin — 1988
• The Role of Factor XI in CoagulationGeorge Broze, David Gailani — 1993
• Surface-dependent reactions of the vitamin K-dependent enzyme complexes.KG Mann, ME Nesheim, W R Church — 1990
• The role of activated human platelets in prothrombin and factor X activation.Jan Rosing, JL van Rijn, EM Bevers — 1985
• Complete Inhibition of Endotoxin-Induced Coagulation Activation in Chimpanzees with a Monoclonal Fab Fragment against Factor VII/VIIaBart J. Biemond, Marcel Levi, Hugo Ten Cate — 1995
• Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay.CF Scott, D Sinha, FS Seaman — 1984
• Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI.Myatt S. Lipscomb, Peter N. Walsh — 1979
• Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen.BN Bouma, RA Vlooswijk, John H. Griffin — 1983
• Blood coagulation in hemophilia A and hemophilia C.Kevin M. Cawthern, Cornelis van ′t Veer, Jennifer B. Lock — 1998
• Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression.Chang-jun Hu, Frank A. Baglia, David C. B. Mills — 1998
• Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders.WH Kane, EW Davie — 1988
• The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin.Hava Peretz, Avital Mulai, Sali Usher — 1997
• Six point mutations that cause factor XI deficiency.RE Pugh, John H. McVey, Edward G. D. Tuddenham — 1995
• Factor XI antigen and activity in human platelets.Tuszynski Gp, SJ Bevacqua, AH Schmaier — 1982
• Effect of Heparin on the Activation of Factor XI by Fibrin-bound ThrombinPeter A. von dem Borne, Joost C.M. Meijers, Bonno N. Bouma — 1996
• Tissue factor and hemostasis.Yale Nemerson — 1988
• Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.Fletcher B. Taylor, A. C. K. Chang, Wolfram Ruf — 1991
• One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews.O Shpilberg, Hava Peretz, Ariella Zivelin — 1995
• The binding of thrombin by fibrin.CHI-YIN LIU, H. L. Nossel, KL Kaplan — 1979
• The role of tissue factor pathway inhibitor in a revised coagulation cascade.George Broze — 1992

Cited by

• Klinische Bewertung potentieller Einsatzbereiche von rekombinantem Faktor VIIa bei internistischen und pädiatrischen ErkrankungenCarl-Erik Dempfle, Dietrich C. Gulba, C.M. Kirchmaier — 2007
• In vitro and in vivo evaluation of blood coagulation activation of polyvinyl alcohol hydrogel plus dextran-based vascular grafts.Nuno Alexandre, Elı́sio Costa, Susana Coimbra — 2015
• Protein C levels as a prognostic indicator of outcome in sepsis and related diseasesCharles J. Fisher, S. Betty Yan — 2000
• A case of chronic myelomonocytic leukaemia and factor XI deficiency with a circulating anticoagulantS. Billon, M. T. Blouch, Martine Escoffre‐Barbe — 2001
• Treatment of factor XI inhibitor using recombinant activated factor VIIaMurray M. Bern, Mervyn A. Sahud, Olga S. Zhukov — 2005
• Detection of single nucleotide polymorphisms in coagulation factor XI deficient patients by multitemperature single‐strand conformation polymorphism analysisAlexandra Bezak, Radosław Kaczanowski, Astrid Dossenbach‐Glaninger — 2005
• Fibrin Clot Formation and Lysis: Basic MechanismsJohannes Jakobsen Sidelmann, Jørgen Gram, Jørgen Jespersen — 2000
• A review of the therapeutic uses of thrombinRalph Bradshaw, Don A. Gabriel, Thomas L. Ortel — 2004
• Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro.Claudia Sperling, Katrin Salchert, Uwe Streller — 2004
• Coagulation factor XI: a database of mutations and polymorphisms associated with factor XI deficiencyAstrid Dossenbach‐Glaninger, P. Hopmeier — 2005
• Comparative aspects of blood coagulation.Patricia A. Gentry — 2004
• Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic feverEric C. M. Van Gorp, Monique C. Minnema, Catharina Suharti — 2001
• Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.Michael B. Boffa, Marlys L. Koschinsky — 2007
• Tissue factor pathway of coagulation in sepsisC. Erik Hack — 2000
• Bleeding and clotting problems during the perioperative periodAllen Silbergleit, Eberhard Mammen — 1999
• Thrombin Inhibitors from Different AnimalsAnita Mitico Tanaka-Azevedo, K. Morais-Zani, Ricardo J.S. Torquato — 2010
• Higher risk of ischaemic stroke associated with factor XI levels in dyslipidaemic patientsAmparo Santamaría, Arturo Oliver, M. Borrell — 2007
• Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitorsGili Kenet, Aaron Lubetsky, Jacob Luboshitz — 2009
• Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence.ATA Mairuhu, MR Mac Gillavry, TE Setiati — 2003
• Biochemistry of serine protease inhibitors and their mechanisms of action: a review.Julie Wegner — 2003

Related papers

No related papers recorded.